Pitfalls in the diagnosis of autoantibodies associated with paraneoplastic neurologic disease
Authors:
- G. ManleyGMG. Manley
- J.W.B. MollJMJ.W.B. Moll
- J. DalmauJDJ. Dalmau
- J. B. PosnerJPJ. B. Posner
- 1 June 1996
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 46 (6) , 1739-1741
Abstract
We studied the sera of 15 patients with Sjogren9s syndrome using the Western blot technique for the presence of anti-Ro and anti-Hu (type 1 antineuronal nuclear autoantibody [ANNA-1]). All sera reacted with Ro-52 protein. Two of the Sjogren sera reacted with 38-kd bands on Western blots of rat cerebellar homogenate, resembling anti-Hu immunoreactivity. However, when reacted with purified human Purkinje cells or purified recombinant HuD protein, none of the sera immunoreacted with the Hu antigens. We recommend the use of either a recombinant Hu protein or the combination of immunohistochemistry and Western blot of purified human neuronal preparations to identify paraneoplastic antibodies. This approach will prevent the unnecessary workup for suspected lung cancer. NEUROLOGY 1996;46: 1739-1741Keywords
This publication has 4 references indexed in Scilit:
- Cystic fibrosis gene and mucin secretionThe Lancet, 1994
- Proliferative potential and prognostic evaluation of low-grade astrocytomasJournal of Neuro-Oncology, 1994
- Magnetic resonance imaging of the shoulder in patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1990
- Pain in sciatica depresses lower limb nociceptive reflexes to sural nerve stimulation.Journal of Neurology, Neurosurgery & Psychiatry, 1987